Related Experiment Video
Updated: Feb 22, 2026
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Blood lactate kinetics as biomarkers of MRI brain injury in neonatal encephalopathy
Giulia Bassani1, Marion Décaillet2,3,4, Patric Hagmann3
1Clinic of Neonatology, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. giulia.bassani00@gmail.com.
Background:
In neonatal encephalopathy (NE), early biomarkers are needed to enhance prognostic accuracy. We hypothesized that blood lactate kinetics correlate with magnetic resonance imaging (MRI)-based brain injury severity.
Methods:
In this prospective cohort study, patients with NE admitted to a tertiary neonatal intensive care unit underwent brain MRI within the first week of life. Injury severity was graded using a validated MRI scoring system, with neonates categorized into low severity (LS) or high severity (HS) groups based on the 75th percentile of the total score. Lactate kinetics were evaluated through peak lactate levels, time to lactate normalization (TLN), and area under the curve (AUC). Associations between lactate kinetics and MRI scores were analyzed.
Results:
Among forty‑eight neonates, 83% underwent therapeutic hypothermia. Compared with the LS group, the HS group had more seizures, higher Thompson and Sarnat scores, and more abnormal neurological exams at discharge. Peak lactate was higher in the HS group (p = 0.02) and correlated with MRI grey matter subscores (p = 0.004). Lactate AUC and TLN were positively associated with MRI total and grey matter scores (all p < 0.01).
Conclusion:
Lactate kinetics are associated with MRI-assessed brain injury severity in NE and may help stratification to tailor therapeutic strategies.
Impact:
Blood lactate kinetics are associated with MRI-assessed brain injury severity in neonates with neonatal encephalopathy (-NE-). This study highlights the value of serial lactate measures, beyond single time-point levels, in early prognostication. Combining biochemical markers with imaging scores may improve the identification of infants at high risk of adverse outcomes. These findings support the potential use of lactate kinetics to stratify patients and guide future therapeutic strategies.
